The APAC Biguanide market, a $1.97 billion industry in 2025, is poised for steady growth driven by rising Type 2 diabetes cases. Explore market trends, segmentation analysis (immediate-release, extended-release, fixed-dose combinations), key players (Takeda, Sanofi, Merck), and regional insights (China, India, Japan) in this comprehensive market overview.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.